{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T21:39:33Z","timestamp":1788730773509,"version":"build-2803163510"},"reference-count":85,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Valeant Pharmaceuticals North America LLC"}],"content-domain":{"domain":["jsm.jsexmed.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The neurobiology of sexual response is driven in part by dopamine and serotonin\u2014the former modulating excitatory pathways and the latter regulating inhibitory pathways. Neurobiological underpinnings of hypoactive sexual desire disorder (HSDD) are seemingly related to overactive serotonin activity that results in underactive dopamine activity. As such, pharmacologic agents that decrease serotonin, increase dopamine, or some combination thereof, have therapeutic potential for HSDD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To review the role of serotonin in female sexual function and the effects of pharmacologic interventions that target the serotonin system in the treatment of HSDD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Searches of the Medline database for articles on serotonin and female sexual function.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Outcomes<\/jats:title>\n                  <jats:p>Relevant articles from the peer-reviewed literature were included.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Female sexual response is regulated not only by the sex hormones but also by several neurotransmitters. It is postulated that dopamine, norepinephrine, oxytocin, and melanocortins serve as key neuromodulators for the excitatory pathways, whereas serotonin, opioids, and endocannabinoids serve as key neuromodulators for the inhibitory pathways. Serotonin appears to be a key inhibitory modulator of sexual desire, because it decreases the ability of excitatory systems to be activated by sexual cues. Centrally acting drugs that modulate the excitatory and inhibitory pathways involved in sexual desire (eg, bremelanotide, bupropion, buspirone, flibanserin) have been investigated as treatment options for HSDD. However, only flibanserin, a multifunctional serotonin agonist and antagonist (5-hydroxytryptamine [5-HT]1A receptor agonist and 5-HT2A receptor antagonist), is currently approved for the treatment of HSDD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Clinical Implications<\/jats:title>\n                  <jats:p>The central serotonin system is 1 biochemical target for medications intended to treat HSDD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Strengths and Limitations<\/jats:title>\n                  <jats:p>This narrative review integrates findings from preclinical studies and clinical trials to elucidate neurobiological underpinnings of HSDD but is limited to 1 neurotransmitter system (serotonin).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Serotonin overactivity is a putative cause of sexual dysfunction in patients with HSDD. The unique pharmacologic profile of flibanserin tones down inhibitory serotonergic function and restores dopaminergic and noradrenergic function.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1016\/j.jsxm.2017.10.068","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T12:46:09Z","timestamp":1512132369000},"page":"1575-1584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Understanding the Role of Serotonin in Female Hypoactive Sexual Desire Disorder and Treatment Options"],"prefix":"10.1093","volume":"14","author":[{"given":"Harry A.","family":"Croft","sequence":"first","affiliation":[{"name":"CNS Studies \u00a0 , San Antonio, TX ,","place":["USA"]},{"name":"Clinical Trials of Texas Research Center \u00a0 , San Antonio, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,12,1]]},"reference":[{"key":"2024111316224787900_bib1","article-title":"Human sexual response","author":"Masters","year":"1966"},{"key":"2024111316224787900_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3810\/pgm.2010.11.2230","article-title":"Low sexual desire\u2014is it all in her head? Pathophysiology, diagnosis, and treatment of hypoactive sexual desire disorder","volume":"122","author":"Simon","year":"2010","journal-title":"Postgrad Med"},{"key":"2024111316224787900_bib3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ogc.2006.09.005","article-title":"Normal sexual response in women","volume":"33","author":"Rosen","year":"2006","journal-title":"Obstet Gynecol Clin North Am"},{"key":"2024111316224787900_bib4","article-title":"Disorders of sexual desire and other new concepts and techniques in sex therapy","author":"Kaplan","year":"1979"},{"key":"2024111316224787900_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/00926230152035831","article-title":"Human sex-response cycles","volume":"27","author":"Basson","year":"2001","journal-title":"J\u00a0Sex Marital Ther"},{"key":"2024111316224787900_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.psc.2010.01.011","article-title":"Female sexual dysfunction","volume":"33","author":"Clayton","year":"2010","journal-title":"Psychiatr Clin North Am"},{"key":"2024111316224787900_bib7","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/AOG.0b013e3181898cdb","article-title":"Sexual problems and distress in United States women: prevalence and correlates","volume":"112","author":"Shifren","year":"2008","journal-title":"Obstet Gynecol"},{"key":"2024111316224787900_bib8","first-page":"260","article-title":"Epidemiology and neurobiology of female sexual dysfunction","volume":"4","author":"Clayton","year":"2007","journal-title":"J\u00a0Sex Med"},{"key":"2024111316224787900_bib9","first-page":"36","article-title":"Sexual desire and hypoactive sexual desire disorder in women. Introduction and overview. Standard operating procedure (SOP Part 1)","volume":"10","author":"Bitzer","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"2024111316224787900_bib10","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/GME.0000000000000131","article-title":"Hypoactive sexual desire in women","volume":"20","author":"Kingsberg","year":"2013","journal-title":"Menopause"},{"key":"2024111316224787900_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijgo.2010.02.014","article-title":"The pathophysiology of hypoactive sexual desire disorder in women","volume":"110","author":"Clayton","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"2024111316224787900_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/00926238408405794","article-title":"An essay on the nature of sexual desire","volume":"10","author":"Levine","year":"1984","journal-title":"J\u00a0Sex Marital Ther"},{"key":"2024111316224787900_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/009262302317251007","article-title":"Reexploring the concept of sexual desire","volume":"28","author":"Levine","year":"2002","journal-title":"J\u00a0Sex Marital Ther"},{"key":"2024111316224787900_bib14","first-page":"1888","article-title":"Toward a more evidence-based nosology and nomenclature for female sexual dysfunctions\u2014part II","volume":"13","author":"Parish","year":"2016","journal-title":"J\u00a0Sex Med"},{"key":"2024111316224787900_bib15","first-page":"1506","article-title":"Pathways of sexual desire","volume":"6","author":"Pfaus","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"2024111316224787900_bib16","article-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000","edition":"4th ed."},{"key":"2024111316224787900_bib17","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s40263-015-0288-1","article-title":"The female sexual response: current models, neurobiological underpinnings and agents currently approved or under investigation for the treatment of hypoactive sexual desire disorder","volume":"29","author":"Kingsberg","year":"2015","journal-title":"CNS Drugs"},{"key":"2024111316224787900_bib18","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/archinte.168.13.1441","article-title":"Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women","volume":"168","author":"West","year":"2008","journal-title":"Arch Intern Med"},{"key":"2024111316224787900_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.gme.0000172596.76272.06","article-title":"Hypoactive sexual desire disorder in postmenopausal women: US results from the Women\u2019s International Study of Health and Sexuality (WISHeS)","volume":"13","author":"Leiblum","year":"2006","journal-title":"Menopause"},{"key":"2024111316224787900_bib20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1524-4733.2008.00483.x","article-title":"Hypoactive sexual desire disorder in postmenopausal women: quality of life and health burden","volume":"12","author":"Biddle","year":"2009","journal-title":"Value Health"},{"key":"2024111316224787900_bib21","first-page":"118","article-title":"The desire (desire and its effects on female sexuality including relationships) study: emotional impact of low sexual desire and associated distress in a sample of 5,089 European women","volume":"7","author":"Fisher","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"2024111316224787900_bib22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1089\/jwh.2014.4743","article-title":"Attitudinal survey of women living with low sexual desire","volume":"23","author":"Kingsberg","year":"2014","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"2024111316224787900_bib23","article-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","edition":"5th ed."},{"key":"2024111316224787900_bib24","first-page":"2027","article-title":"Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM-V revisions: 1. For women with incomplete loss of desire or sexual receptivity","volume":"9","author":"Clayton","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"2024111316224787900_bib25","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/gme.0b013e318230e286","article-title":"Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women","volume":"19","author":"Rosen","year":"2012","journal-title":"Menopause"},{"key":"2024111316224787900_bib26","first-page":"121","article-title":"The dual control model: current status and future directions","volume":"46","author":"Bancroft","year":"2009","journal-title":"J\u00a0Sex Res"},{"key":"2024111316224787900_bib27","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/sj.mp.4001816","article-title":"How psychotherapy changes the brain\u2014the contribution of functional neuroimaging","volume":"11","author":"Linden","year":"2006","journal-title":"Mol Psychiatry"},{"key":"2024111316224787900_bib28","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1017\/S0033291705005064","article-title":"Neuroimaging and the functional neuroanatomy of psychotherapy","volume":"35","author":"Roffman","year":"2005","journal-title":"Psychol Med"},{"key":"2024111316224787900_bib29","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nrn2345","article-title":"Cognitive therapy vs. medications for depression: treatment outcomes and neural mechanisms","volume":"9","author":"DeRubeis","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"2024111316224787900_bib30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1176\/jnp.2009.21.2.114","article-title":"Does cognitive behavioral therapy change the brain? A systematic review of neuroimaging in anxiety disorders","volume":"21","author":"Ribeiro Porto","year":"2009","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"key":"2024111316224787900_bib31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0193-953X(03)00043-1","article-title":"Sexual function and dysfunction in women","volume":"26","author":"Clayton","year":"2003","journal-title":"Psychiatr Clin North Am"},{"key":"2024111316224787900_bib32","article-title":"Antidepressant-induced sexual dysfunction associated with low serum free testosterone","author":"Cohen"},{"key":"2024111316224787900_bib33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4088\/JCP.10bs06115whi","article-title":"Circuits of sexual desire in hypoactive sexual desire disorder","volume":"71","author":"Stahl","year":"2010","journal-title":"J\u00a0Clin Psychiatry"},{"key":"2024111316224787900_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852914000832","article-title":"Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder","volume":"20","author":"Stahl","year":"2015","journal-title":"CNS Spectr"},{"key":"2024111316224787900_bib35","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4088\/JCP.10bs06425whi","article-title":"Illustrating the circuits of sexual desire","volume":"71","author":"Stahl","year":"2010","journal-title":"J\u00a0Clin Psychiatry"},{"key":"2024111316224787900_bib36","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.neuroscience.2008.09.044","article-title":"Women with hypoactive sexual desire disorder compared to normal females: a functional magnetic resonance imaging study","volume":"158","author":"Arnow","year":"2009","journal-title":"Neuroscience"},{"key":"2024111316224787900_bib37","first-page":"2546","article-title":"Neural bases of hypoactive sexual desire disorder in women: an event-related FMRI study","volume":"8","author":"Bianchi-Demicheli","year":"2011","journal-title":"J\u00a0Sex Med"},{"key":"2024111316224787900_bib38","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.fertnstert.2013.05.041","article-title":"Brain activation patterns in women with acquired hypoactive sexual desire disorder and women with normal sexual function: a cross-sectional pilot study","volume":"100","author":"Woodard","year":"2013","journal-title":"Fertil Steril"},{"key":"2024111316224787900_bib39","article-title":"Biology chapter 35.3, the central nervous system","author":"OpenStax College"},{"key":"2024111316224787900_bib40","doi-asserted-by":"crossref","first-page":"9917","DOI":"10.1523\/JNEUROSCI.21-24-09917.2001","article-title":"Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABA(A), and glutamate receptors","volume":"21","author":"Celada","year":"2001","journal-title":"J\u00a0Neurosci"},{"key":"2024111316224787900_bib41","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1126\/science.1094987","article-title":"Cognitive inflexibility after prefrontal serotonin depletion","volume":"304","author":"Clarke","year":"2004","journal-title":"Science"},{"key":"2024111316224787900_bib42","first-page":"252","article-title":"The therapeutic role of 5-HT1A and 5-HT2A receptors in depression","volume":"29","author":"Celada","year":"2004","journal-title":"J\u00a0Psychiatry Neurosci"},{"key":"2024111316224787900_bib43","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A\u00a0review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"2024111316224787900_bib44","first-page":"48","article-title":"Antidepressant-induced sexual dysfunction","volume":"59","author":"Segraves","year":"1998","journal-title":"J\u00a0Clin Psychiatry"},{"key":"2024111316224787900_bib45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/JCP.0b013e3181a5233f","article-title":"Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis","volume":"29","author":"Serretti","year":"2009","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"2024111316224787900_bib46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0165-0327(98)00221-3","article-title":"Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects","volume":"51","author":"Stahl","year":"1998","journal-title":"J\u00a0Affect Disord"},{"key":"2024111316224787900_bib47","first-page":"15","article-title":"Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder","volume":"8","author":"Stahl","year":"2011","journal-title":"J\u00a0Sex Med"},{"key":"2024111316224787900_bib48","doi-asserted-by":"crossref","first-page":"9856","DOI":"10.1523\/JNEUROSCI.21-24-09856.2001","article-title":"Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism","volume":"21","author":"Mart\u00edn-Ruiz","year":"2001","journal-title":"J\u00a0Neurosci"},{"key":"2024111316224787900_bib49","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1471-4159.2005.03485.x","article-title":"The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity","volume":"95","author":"Bortolozzi","year":"2005","journal-title":"J\u00a0Neurochem"},{"key":"2024111316224787900_bib50","doi-asserted-by":"crossref","first-page":"10831","DOI":"10.1523\/JNEUROSCI.2999-05.2005","article-title":"Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action","volume":"25","author":"D\u00edaz-Mataix","year":"2005","journal-title":"J\u00a0Neurosci"},{"key":"2024111316224787900_bib51","article-title":"Addyi\u00ae (flibanserin) tablets, for oral use [package insert]","year":"2016"},{"key":"2024111316224787900_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1056\/NEJMp1513686","article-title":"FDA approval of flibanserin\u2014treating hypoactive sexual desire disorder","volume":"374","author":"Joffe","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"2024111316224787900_bib53","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1527-3458.2002.tb00219.x","article-title":"Pharmacology of flibanserin","volume":"8","author":"Borsini","year":"2002","journal-title":"CNS Drug Rev"},{"key":"2024111316224787900_bib54","first-page":"3449","article-title":"Flibanserin: initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder","volume":"7","author":"Kennedy","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"2024111316224787900_bib55","first-page":"1074","article-title":"Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study","volume":"9","author":"Derogatis","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"2024111316224787900_bib56","first-page":"793","article-title":"Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study","volume":"9","author":"Thorp","year":"2012","journal-title":"J\u00a0Sex Med"},{"key":"2024111316224787900_bib57","first-page":"1807","article-title":"Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial","volume":"10","author":"Katz","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"2024111316224787900_bib58","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/GME.0000000000000134","article-title":"Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial","volume":"21","author":"Simon","year":"2014","journal-title":"Menopause"},{"key":"2024111316224787900_bib59","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jamainternmed.2015.8565","article-title":"Efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women: a systematic review and meta-analysis","volume":"176","author":"Jaspers","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2024111316224787900_bib60","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2174\/1389200217666161026090333","article-title":"Systematic review and meta-analysis of flibanserin\u2019s effects and adverse events in women with hypoactive sexual desire disorder","volume":"18","author":"Saadat","year":"2017","journal-title":"Curr Drug Metab"},{"key":"2024111316224787900_bib61","first-page":"2095","article-title":"Efficacy and safety of flibanserin in women with hypoactive sexual desire disorder: a systematic review and meta-analysis","volume":"12","author":"Gao","year":"2015","journal-title":"J\u00a0Sex Med"},{"key":"2024111316224787900_bib62","article-title":"International Society for the Study of Women\u2019s Sexual Health Inc. Press release"},{"key":"2024111316224787900_bib63","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/0092623X.2017.1280865","article-title":"Is flibanserin meaningfully superior to placebo?","volume":"43","author":"Clayton","year":"2017","journal-title":"J\u00a0Sex Marital Ther"},{"key":"2024111316224787900_bib64","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/jcpt.12563","article-title":"The pharmacodynamic effects of combined administration of flibanserin and alcohol","volume":"42","author":"Stevens","year":"2017","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"2024111316224787900_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsxm.2017.04.569","article-title":"Effect of alcohol administered with flibanserin on dizziness, syncope, and hypotension in healthy, premenopausal women","volume-title":"Presented at: 23rd Congress of the World Association for Sexual Health","author":"Sicard","year":"2017"},{"key":"2024111316224787900_bib66","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.bjp.0705341","article-title":"Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors","volume":"139","author":"Invernizzi","year":"2003","journal-title":"Br J Pharmacol"},{"key":"2024111316224787900_bib67","first-page":"276","article-title":"BIMT 17, a 5-HT2A receptor antagonist and 5-HT1A receptor full agonist in rat cerebral cortex","volume":"352","author":"Borsini","year":"1995","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2024111316224787900_bib68","first-page":"283","article-title":"BIMT 17, a 5-HT1A receptor agonist\/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex","volume":"352","author":"Borsini","year":"1995","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2024111316224787900_bib69","first-page":"1757","article-title":"Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: a microdialysis study","volume":"7","author":"Allers","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"2024111316224787900_bib70","doi-asserted-by":"crossref","first-page":"e2603","DOI":"10.1002\/hup.2603","article-title":"Next-day residual effects of flibanserin on simulated driving performance in premenopausal women","volume":"32","author":"Kay","year":"2017","journal-title":"Hum Psychopharmacol"},{"key":"2024111316224787900_bib71","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s11095-011-0648-6","article-title":"Population pharmacokinetic\/pharmacodynamic model for the sedative effects of flibanserin in healthy volunteers","volume":"29","author":"Troconiz","year":"2012","journal-title":"Pharm Res"},{"key":"2024111316224787900_bib72","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1517\/14656566.2015.1090426","article-title":"Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women","volume":"16","author":"Dhanuka","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"2024111316224787900_bib73","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S1461145702002869","article-title":"Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain","volume":"5","author":"Marazziti","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"2024111316224787900_bib74","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2012.04.032","article-title":"Buspirone: what is it all about?","volume":"1461","author":"Loane","year":"2012","journal-title":"Brain Res"},{"key":"2024111316224787900_bib75","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00004714-199906000-00012","article-title":"Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors","volume":"19","author":"Land\u00e9n","year":"1999","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"2024111316224787900_bib76","first-page":"201","article-title":"Effect of buspirone on sexual dysfunction in patients with generalized anxiety disorder","volume":"48","author":"Othmer","year":"1987","journal-title":"J\u00a0Clin Psychiatry"},{"key":"2024111316224787900_bib77","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1176\/appi.ajp.157.2.239","article-title":"Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention","volume":"157","author":"Michelson","year":"2000","journal-title":"Am J Psychiatry"},{"key":"2024111316224787900_bib78","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pbb.2014.02.002","article-title":"Two novel combined drug treatments for women with hypoactive sexual desire disorder","volume":"121","author":"Poels","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"2024111316224787900_bib79","first-page":"824","article-title":"Toward personalized sexual medicine (part 3): testosterone combined with a serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms","volume":"10","author":"van Rooij","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"2024111316224787900_bib80","first-page":"1411","article-title":"Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women","volume":"8","author":"Fabre","year":"2011","journal-title":"J\u00a0Sex Med"},{"key":"2024111316224787900_bib81","first-page":"2569","article-title":"Gepirone-ER treatment of low sexual desire associated with depression in women as measured by the DeRogatis Inventory of Sexual Function (DISF) fantasy\/cognition (desire) domain\u2014a post hoc analysis","volume":"8","author":"Fabre","year":"2011","journal-title":"J\u00a0Sex Med"},{"key":"2024111316224787900_bib82","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1464-410X.2003.04358.x","article-title":"Trazodone for erectile dysfunction: a systematic review and meta-analysis","volume":"92","author":"Fink","year":"2003","journal-title":"BJU Int"},{"key":"2024111316224787900_bib83","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/WNF.0b013e31816d1cdc","article-title":"Trazodone for the treatment of sexual dysfunction induced by serotonin reuptake inhibitors: a preliminary open-label study","volume":"32","author":"Stryjer","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"2024111316224787900_bib84","article-title":"Phase IIa study of a proprietary combination of bupropion and trazodone for hypoactive sexual desire disorder (HSDD) in premenopausal women: novel responder and remitter results [poster]","volume-title":"Presented at: Annual Meeting American Society of Clinical Psychopharmacology","author":"Pyke","year":"2015"},{"key":"2024111316224787900_bib85","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2217\/whe-2016-0018","article-title":"Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial","volume":"12","author":"Clayton","year":"2016","journal-title":"Womens Health (Lond)"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609517315394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609517315394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/14\/12\/1575\/60418600\/jsm_14_12_1575.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/14\/12\/1575\/60418600\/jsm_14_12_1575.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T16:38:20Z","timestamp":1731515900000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/14\/12\/1575\/6973348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,1]]},"references-count":85,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,1]]},"published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.jsxm.2017.10.068","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2017,12,1]]},"published":{"date-parts":[[2017,12,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the Role of Serotonin in Female Hypoactive Sexual Desire Disorder and Treatment Options","name":"articletitle","label":"Article Title"},{"value":"The Journal of Sexual Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsxm.2017.10.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}